Eli Lilly and Co
SIX:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
SIX:LLY
|
US |
|
First Real Estate Investment Trust of New Jersey Inc
OTC:FREVS
|
US |
|
Look Holdings Inc
F:LOO
|
JP |
|
T
|
Telefonaktiebolaget LM Ericsson
XHAM:ERCB
|
SE |
|
Superloop Ltd
F:9SL
|
AU |
Intrinsic Value
Is LLY undervalued or overvalued?
See the intrinsic value estimate for 
Eli Lilly and Co and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
LLY looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with LLY’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Eli Lilly and Does
Eli Lilly is a pharmaceutical company that discovers, develops, makes, and sells prescription medicines. Its products treat major disease areas such as diabetes, obesity, cancer, immune disorders, and neurological conditions. The company does not sell consumer goods; it sells regulated drugs that patients get through doctors, pharmacies, hospitals, and health plans.
- Headquarters
- United States of America US
- Employees
- 50 000
- IPO date
- Jul 9, 1970
Revenue & Expenses Breakdown
Eli Lilly and Co
Earnings Waterfall
Eli Lilly and Co
The intrinsic value for Eli Lilly and Co (LLY) under the Base Case is hidden CHF.
Compared with the current market price of 1 050 CHF, the stock appears hidden.